
Mai Peptide
Tirzepatide
Finnrick tested 24 samples of Tirzepatide (GLP-1 and GIP agonist) from Mai Peptide between 25 Nov 2025 and 21 Aug 2026. Test scores average below 4 or some scores below 3, and at least 6 tests, warrant a confident Finnrick Rating of E (Bad).
Finnrick Rating™
Mai Peptide
Tirzepatide
Tested 24 Samples
Last test 21 Aug 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Tirzepatide tests from top-rated vendors:
All Tirzepatide tests from Mai Peptide
Samples are tested in commercial labs
Tests Count
24
Scores
AVGMINMAX
Last
21 Aug 2026
First
25 Nov 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 21 Aug 2026 | View | 50mg | ⚠️ Sample does not contain Tirzepatide | 060420017 | No label, Gold crimp, Violet cap | Lab G | Public | |||
| 30 Jul 2026 | View | 40mg | ⚠️ Sample does not contain Tirzepatide | MP40626 | No Label / Silver Crimp / Clear Blue Cap | Lab G | Public | |||
| 1 Jul 2026 | View | 30mg | 32.1mg | +7.0% | 99.90% | March 6 2026 | Silver label / Silver crimp / Black cap | Lab E | Public | |
| 8 Jun 2026 | View | 30mg | 39.3mg | +31.0% | 99.80% | January 4, 2026 | No label / Silver crimp / Black cap | Lab G | Public | |
| 6 Mar 2026 | View | 60mg | 70.2mg | +17.0% | 99.90% | October 18,2025 | No Label / Copper Crimp / Clear Cap | Lab E | Public | |
| 6 Mar 2026 | View | 50mg | 52.4mg | +4.8% | 99.90% | October 20,2025 | No Label / Silver Crimp / Clear Yellow Cap | Lab E | Public | |
| 6 Mar 2026 | View | 60mg | 51.7mg | -13.8% | 99.90% | 1/04/2026 | No Label / Copper Crimp / Clear Cap | Lab E | Public | |
| 6 Mar 2026 | View | 50mg | 42.4mg | -15.2% | 99.90% | (no batch ID) | No Label / Silver Crimp / White Cap | Lab E | Public | |
| 4 Mar 2026 | View | 30mg | 25.3mg | -15.7% | 99.06% | December 25, 2025 | Teal Label / Silver Crimp / Green Cap | Lab E | Public | |
| 18 Feb 2026 | View | 30mg | 31.5mg | +5.0% | 98.92% | Mai11052025TR30 | Silver Label / Silver Crimp / Black Cap | Lab E | Public | |
| 4 Feb 2026 | View | 10mg | 10.8mg | +8.0% | 99.70% | (no batch ID) | No Label / Silver Crimp / Clear Green Cap | Lab G | Public | |
| 4 Feb 2026 | View | 10mg | 10.6mg | +6.0% | 99.70% | (no batch ID) | No Label / Silver Crimp / Clear Green Cap | Lab G | Public | |
| 2 Feb 2026 | View | 40mg | 41.8mg | +4.5% | 99.25% | (no batch ID) | White Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 2 Feb 2026 | View | 50mg | 40.9mg | -18.2% | 96.40% | (no batch ID) | White Label / Silver Crimp / Orange Cap | Lab E | Public | |
| 2 Feb 2026 | View | 40mg | 40.9mg | +2.3% | 99.12% | 12/2025 | Silver Label / Silver Crimp / Green Cap | Lab E | Public | |
| 2 Feb 2026 | View | 60mg | 65.3mg | +8.8% | 99.46% | 12/2025 | Silver Label / Copper Crimp / Clear Cap | Lab E | Public | |
| 2 Feb 2026 | View | 30mg | 32.4mg | +8.0% | 99.10% | 12/2025 | Silver Label / Silver Crimp / Green Cap | Lab E | Public | |
| 29 Jan 2026 | View | 50mg | 49.7mg | -0.6% | 99.90% | October 20, 2025 | No Label / Silver Crimp / Red Cap | Lab E | Public | |
| 19 Jan 2026 | View | 60mg | 57mg | -5.0% | 99.95% | October 8 2025 | White Label / Silver Crimp / Pink Cap | Lab E | Public | |
| 15 Jan 2026 | View | 30mg | 33.2mg | +10.7% | 99.54% | 15734916854 | Red Label / Silver Crimp / Green Cap | Lab E | Public | |
| 9 Jan 2026 | View | 30mg | 28mg | -6.7% | 99.31% | 11/05/2025 | White Label / Silver Crimp / Black Cap | Lab E | Public | |
| 1 Jan 2026 | View | 10mg | 9.2mg | -8.0% | 99.70% | (no batch ID) | (no data) | Lab G | Public | |
| 17 Dec 2025 | View | 30mg | 28.9mg | -3.7% | 99.68% | 10-08-2025 | White Label / Silver Crimp / Green Cap | Lab E | Public | |
| 25 Nov 2025 | View | 20mg | ⚠️ Sample does not contain Tirzepatide | 10/8/2025 - Purple Cap | White Label / Silver Crimp / Violet Cap | Lab E | Public | |||